. . . . . . . . "Nilima Arun Kshirsagar (1949) \u00E8 una farmacologa indiana che ha sviluppato e brevettato l'amfotericina B liposomiale e il suo sistema di somministrazione di farmaci nel 1993. \u00C8 l'ex preside del King Edward Memorial Hospital e del Seth Gordhandas Sunderdas Medical College. \u00C8 il presidente nazionale in farmacologia clinica presso l'Indian Council of Medical Research (ICMR) e presidente del capitolo dell'Asia meridionale del college americano di farmacologia clinica. \u00C8 membro dei comitati dell'OMS per lo sviluppo dei prodotti e la metodologia delle statistiche sui farmaci. Kshirsagar \u00E8 membro della National Academy of Sciences, India, membro del Searle Research Center, Inghilterra, della Facolt\u00E0 di Medicina Farmaceutica del Regno Unito e membro dell'American College of Clinical Pharmacology, USA. \u00C8 presidente del gruppo di formazione di base del programma di farmacovigilanza dell'India. Ha fondato i dipartimenti di farmacologia clinica presso il KEM Hospital e il Nair Hospital di Mumbai. Il farmaco Liposomal Amphotericin-b, usato per trattare l'epidemia di mucormicosi indiana del 2021, \u00E8 stato sviluppato e brevettato in India da Nalini Kshirsagar nel 1993."@it . . . . . . . . . . . "67784968"^^ . . . . . . . . . . . . . . . . . . . "Nilima Arun Kshirsagar"@en . . . . "Clinical Pharmacologists"@en . . "20168"^^ . . . . "Nilima Arun Kshirsagar"@it . . . . . "Liposomal Formulations"@en . . . . . . . . . . "Nilima Arun Kshirsagar"@en . . . . . . . . . . . . . "Nilima Arun Kshirsagar FACCP, FRCP, FNAMS FNAS (born 1949) is an Indian clinical pharmacologist who developed and patented liposomal amphotericin B and its drug delivery system in 1993. She is the former dean of King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College. She is the national chairperson in clinical pharmacology at Indian Council of Medical Research (ICMR) and president of the South Asian chapter of the American college of clinical pharmacology. She is a Member of the WHO Committees on Product development and Drug statistics Methodology."@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . ""@en . . "1064764347"^^ . . . "Nilima Arun Kshirsagar"@en . . . . . . . . . . . . . . . . . . . "Nilima Arun Kshirsagar (1949) \u00E8 una farmacologa indiana che ha sviluppato e brevettato l'amfotericina B liposomiale e il suo sistema di somministrazione di farmaci nel 1993. \u00C8 l'ex preside del King Edward Memorial Hospital e del Seth Gordhandas Sunderdas Medical College. \u00C8 il presidente nazionale in farmacologia clinica presso l'Indian Council of Medical Research (ICMR) e presidente del capitolo dell'Asia meridionale del college americano di farmacologia clinica. \u00C8 membro dei comitati dell'OMS per lo sviluppo dei prodotti e la metodologia delle statistiche sui farmaci."@it . . . . . . "Nilima Arun Kshirsagar FACCP, FRCP, FNAMS FNAS (born 1949) is an Indian clinical pharmacologist who developed and patented liposomal amphotericin B and its drug delivery system in 1993. She is the former dean of King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College. She is the national chairperson in clinical pharmacology at Indian Council of Medical Research (ICMR) and president of the South Asian chapter of the American college of clinical pharmacology. She is a Member of the WHO Committees on Product development and Drug statistics Methodology. Kshirsagar is a fellow of the National Academy of Sciences, India, a fellow of the Searle Research Center, England, Faculty of Pharmaceutical Medicine UK and Fellow of American College of Clinical Pharmacology, USA. She is the Chair of the core training Panel of Pharmacovigilance Programme of India. She established departments of Clinical Pharmacology at KEM Hospital and at Nair Hospital Mumbai. The drug Liposomal Amphotericin-b, used to treat the Indian Mucormycosis epidemic of 2021 was developed and patented in India by Nalini Kshirsagar in 1993."@en . . . . . . . . . . . . .